SoftOx Solutions AS: Annual Report 2025

SoftOx Solutions AS (SoftOx) announces that it has published its Annual Report for 2025. The Board of Directors has approved the 2025 annual financial statements prepared in accordance with the Norwegian Accounting Act and accounting standards and practices generally accepted in Norway. The documents are also available at the Company's website, https://soft-ox.com

For further information, please contact:

Ulrik Spork, COB Soft Solutions AS, +45 31 38 83 87

Ingrid Juven, CFO SoftOx Solutions AS, +47 918 76 165

Mail: ir@soft-ox.com

About SoftOx Solutions AS:

SoftOx Solutions AS (ticker: SOFTX) is a clinical-stage pharmaceutical company listed on Euronext Growth Oslo. The company is developing highly effective pan-antimicrobial pharmaceuticals targeting bacteria, viruses, and fungi. The technology is based on extensive research and development in partnership with leading Nordic research institutes.